Publication:
Pharmacotherapy of Hospitalized Patients with COVID-19 at a Tertiary Care Hospital in Nepal

Simple item page
creativeworkseries.issnISSN (Print) : 1993-2979 | ISSN (Online) : 1993-2987
dc.contributor.authorMudvari, Anish
dc.contributor.authorPrasad, Pravin
dc.contributor.authorPokharel, Akritee
dc.contributor.authorThapaliya, Sabin
dc.contributor.authorMaharjan, Bindira
dc.contributor.authorKhadka, Rebanta
dc.contributor.authorLamsal, Arun Batsa
dc.contributor.authorGhimire, Ranjeet
dc.contributor.authorBista, Apeksha
dc.date.accessioned2025-11-03T08:25:27Z
dc.date.available2025-11-03T08:25:27Z
dc.date.issued2025
dc.descriptionAnish Mudvari Maharajgunj Medical Campus, Tribhuvan University Author https://orcid.org/0000-0002-0509-2982 Pravin Prasad Author Akritee Pokharel Author Sabin Thapaliya Author Bindira Maharjan Author Rebanta Khadka Author Arun Batsa Lamsal Author Ranjeet Ghimire Author Apeksha Bista Author
dc.description.abstractABSTRACT: Introduction The COVID-19 pandemic poses a major health threat with no standardized treatments for SARS-CoV-2. This study evaluates pharmacotherapy trends in COVID-19 patients during the second wave at a tertiary care facility. Methods A retrospective, observational, cross-sectional study was conducted in a tertiary care centre, utilising patient data from April 2021 to July 2021. The sample included 310 patients admitted with a confirmed diagnosis of COVID-19. Patients were classified based on oxygen requirement levels, and data were analysed using descriptive statistics. Results Of the 310 patients, 59% were male and 41% female, with a mean age of 53.37 ± 17.01 years. The average hospital stay was 10 ± 7.15 days. Most patients (66.8%) required supplemental oxygen, and 7.4% required mechanical ventilation. The majority received antibacterial therapy (307, 99.03%), with ceftriaxone being the most commonly prescribed antibiotic (73.22%). Remdesivir was the predominant antiviral, and dexamethasone was used in 88.39% of patients. Conclusion Antibiotic use was extensive among hospitalised COVID-19 patients, with ceftriaxone being the most common. Antiviral use was less frequent, with Remdesivir being the preferred choice. Dexamethasone played a crucial role in managing severe cases.
dc.identifierhttps://doi.org/10.59779/jiomnepal.1335
dc.identifier.urihttps://hdl.handle.net/20.500.14572/3018
dc.language.isoen_US
dc.publisherInstitute of Medicine, Tribhuvan University
dc.subjectCOVID-19
dc.subjectpharmacotherapy
dc.subjectantibacterial
dc.subjectremdesivir
dc.subjectdexamethasone
dc.subjectNepal
dc.subjecthospitalized patients
dc.titlePharmacotherapy of Hospitalized Patients with COVID-19 at a Tertiary Care Hospital in Nepal
dc.typeArticle
dspace.entity.typePublication
local.article.typeOriginal Article
oaire.citation.endPage48
oaire.citation.startPage44
relation.isJournalIssueOfPublication36785908-a57b-42f4-961a-9168ac067265
relation.isJournalIssueOfPublication.latestForDiscovery36785908-a57b-42f4-961a-9168ac067265
relation.isJournalOfPublicationa9ba45d9-ee33-4a6b-b1fc-6626b87eec6c

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
44-48.pdf
Size:
347.17 KB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.86 KB
Format:
Item-specific license agreed to upon submission
Description:
Download

Collections

Publications

Connect with us

Nepal Health Research Council © 2023
Ramshah Path, Kathmandu Nepal P.O.Box 7626